A new study published in the BMJ Supportive and Palliative Care journal suggests that doctors may be able to predict whether ...
US FDA approves Regeneron’s gene therapy, Otarmeni for genetic hearing loss: Tarrytown, New York Regeneron Pharmaceuticals, Inc., a leadi ...
Traditional explanations of acupuncture often emphasize direct acupoint-organ relationships, focusing on local stimulation or ...
The FDA has granted accelerated approval to Otarmeni™ (lunsotogene parvec-cwha), the first gene therapy for pediatric and adult patients with OTOF-related sensorineural hearing loss.
Researchers introduce Cheese3D, an AI tool that tracks mouse facial expressions to predict brain states and anesthesia depth with EEG accuracy.
The FDA has granted an accelerated approval for Otarmeni (lunsotogene parvec-cwha), the first gene therapy to treat patients ...
Approval in severe-to-profound and profound OTOF -related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of ...
MedPage Today on MSN
First Gene Therapy Approved for Hearing Loss
Maker says Otarmeni will be offered for free in the U.S.
Lifestyle contributor Sherry Mukasa Matemachani discussed the gut-brain axis and its connection to stress, as well as tools and techniques for managing stress, such as the Nuna Emotion Tracker, ...
A recent study revealed that serotonin, a neurotransmitter known for regulating moods, may play a pivotal role in tinnitus, a ...
A study reveals that early patterns of stress-driven drinking may quietly reshape the brain in ways that persist into midlife ...
Crack open any biology textbook, and you’ll find tidy diagrams, clean labels, and plenty of comforting facts about the human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results